ADIPOQ and blue cone monochromacy: Excluding patients with metastases did not change the estimates for adiponectin, but eliminated the association of continuous resistin with BCM in ERPR negative disease (HR 1.09, 95% CI 0.85–1.40) (supplemental Table S6).